USER ID: 
 PASSWORD: 
Course Overview

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Explain the debate over whether levodopa is potentially neurotoxic to remaining dopaminergic neurons in Parkinson’s disease
  • Recognize the range of motor complications caused by levodopa and the mechanism responsible for their development
  • Recognize the therapeutic usefulness of levodopa in the treatment of Parkinson’s disease
Jointly sponsored by:
Co-sponsored by The Movement Disorder Society
and the Center for Advanced Medical Education, Inc.

Support for this activity has been made possible
through an education grant from Novartis Pharmaceutical Corporation.

- Release Date: TBD
- Expiration Date: TBD
- Estimated time to complete this educational activity : 1.5 Hours
(c) 2006 The Movement Disorder Society & The Center for Advanced Medical Education. All rights reserved. Privacy Statement